Please login to the form below

Not currently logged in
Email:
Password:

PharmApprove appoints Solvay's Coos De Graaf

He will to lead the agency's new European office

PharmApprove Coos De GraafRegulatory and scientific communications firm PharmApprove has opened a European office and appointed Coos De Graaf to lead its operations in the region.  

De Graaf, who joins as principal for commercial operations in Europe, has more than 30 years' experience in pharma, including numerous roles in senior management.  

He moves to PharmApprove, a New Jersey, US-headquartered division of Taft and Partners, from Solvay Pharmaceuticals, where he led various functions, including global compliance and clinical and commercial development.  

The opening of a European office signals, said PharmApprove, “a new push towards expanded services and geographic markets”. Under De Graaf's leadership, PharmApprove will continue to support clients preparing to bring new therapeutic agents and devices before assessment agencies.  

"PharmApprove has established client experience in Europe, but adding a leader of Coos De Graaf's calibre positions us extremely well to continue growing to serve our clients globally," said PharmApprove president Laurie Smaldone.   

"In addition we are excited to announce expanded services building upon our success in supporting product approvals to include market access communication support."   

Along with expanding its services, PharmApprove has outlined three key areas of focus: advisory committee preparation, regulatory communication and market access communications support.

24th December 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics